单通道阴道筒与徒手间质针阴道近距离治疗妇科肿瘤的剂量学比较。

IF 1.1 4区 医学 Q4 ONCOLOGY
Journal of Contemporary Brachytherapy Pub Date : 2024-06-01 Epub Date: 2024-06-28 DOI:10.5114/jcb.2024.141169
Kaiqiang Chen, Yanhong Zhuo, Zirong Li, Penggang Bai, Jihong Chen, Yibin Lin, Jing Liu, Li Li, Yang Yang, Junping Pan, Yanwen Song, Tianming Wu, Xiuchun Zhang, Qin Xu
{"title":"单通道阴道筒与徒手间质针阴道近距离治疗妇科肿瘤的剂量学比较。","authors":"Kaiqiang Chen, Yanhong Zhuo, Zirong Li, Penggang Bai, Jihong Chen, Yibin Lin, Jing Liu, Li Li, Yang Yang, Junping Pan, Yanwen Song, Tianming Wu, Xiuchun Zhang, Qin Xu","doi":"10.5114/jcb.2024.141169","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To compare the dosimetric differences in vaginal brachytherapy (VBT) using single-channel vaginal cylinder (SCVC) and free-hand interstitial needles (FIN).</p><p><strong>Material and methods: </strong>Twenty-two women with malignant gynecologic tumors were prospectively treated with image-guided high-dose-rate (HDR) brachytherapy after surgery and external beam radiation therapy (EBRT). All HDR treatments were delivered using FIN implant technique. For dosimetric comparison purposes only, SCVCs of 2.5 cm diameter were placed in all patients. No sources were dwelled in cylinder applicator during clinical treatment. CT-guided brachytherapy treatment planning was performed according to GEC-ESTRO guidelines, with high-risk clinical target volume (HR-CTV) delineated based on clinical exams and MRI T2 sequences. Dose-volume parameters to HR-CTV and surrounding organs at risk (OARs) from interstitial plans were compared with those achieved from cylinder plans.</p><p><strong>Results: </strong>Compared with SCVC group, FIN group showed the same HR-CTV coverage. FIN group had higher V<sub>150%</sub> and V<sub>200%</sub> (<i>p</i> < 0.05). In addition, it had lower HI (<i>p</i> < 0.05). However, doses to the rectum D<sub>0.1cc</sub> (538.5 ±119.8 cGy), D<sub>1cc</sub> (415.4 ±73.3 cGy), D<sub>2cc</sub> (355.7 ±66.6 cGy), and D<sub>mean</sub> (162.8 ±43.7 cGy) as well as the bladder D<sub>0.1cc</sub> (516.1 ±85.2 cGy) and D<sub>1cc</sub> (392.9 ±59.8 cGy) were lower in FIN group than in SCVC group (<i>p</i> < 0.05).</p><p><strong>Conclusions: </strong>FIN technique can be a dosimetrically preferable alternative to the commonly used SCVC for HDR VBT boost in patients with gynecological malignancies. It provides adequate coverage of target volumes, with minimal radiation dose to surrounding organs at risk.</p>","PeriodicalId":51305,"journal":{"name":"Journal of Contemporary Brachytherapy","volume":"16 3","pages":"219-224"},"PeriodicalIF":1.1000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11609860/pdf/","citationCount":"0","resultStr":"{\"title\":\"Dosimetric comparison between single-channel vaginal cylinder and free-hand interstitial needles in vaginal brachytherapy of gynecological cancers.\",\"authors\":\"Kaiqiang Chen, Yanhong Zhuo, Zirong Li, Penggang Bai, Jihong Chen, Yibin Lin, Jing Liu, Li Li, Yang Yang, Junping Pan, Yanwen Song, Tianming Wu, Xiuchun Zhang, Qin Xu\",\"doi\":\"10.5114/jcb.2024.141169\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To compare the dosimetric differences in vaginal brachytherapy (VBT) using single-channel vaginal cylinder (SCVC) and free-hand interstitial needles (FIN).</p><p><strong>Material and methods: </strong>Twenty-two women with malignant gynecologic tumors were prospectively treated with image-guided high-dose-rate (HDR) brachytherapy after surgery and external beam radiation therapy (EBRT). All HDR treatments were delivered using FIN implant technique. For dosimetric comparison purposes only, SCVCs of 2.5 cm diameter were placed in all patients. No sources were dwelled in cylinder applicator during clinical treatment. CT-guided brachytherapy treatment planning was performed according to GEC-ESTRO guidelines, with high-risk clinical target volume (HR-CTV) delineated based on clinical exams and MRI T2 sequences. Dose-volume parameters to HR-CTV and surrounding organs at risk (OARs) from interstitial plans were compared with those achieved from cylinder plans.</p><p><strong>Results: </strong>Compared with SCVC group, FIN group showed the same HR-CTV coverage. FIN group had higher V<sub>150%</sub> and V<sub>200%</sub> (<i>p</i> < 0.05). In addition, it had lower HI (<i>p</i> < 0.05). However, doses to the rectum D<sub>0.1cc</sub> (538.5 ±119.8 cGy), D<sub>1cc</sub> (415.4 ±73.3 cGy), D<sub>2cc</sub> (355.7 ±66.6 cGy), and D<sub>mean</sub> (162.8 ±43.7 cGy) as well as the bladder D<sub>0.1cc</sub> (516.1 ±85.2 cGy) and D<sub>1cc</sub> (392.9 ±59.8 cGy) were lower in FIN group than in SCVC group (<i>p</i> < 0.05).</p><p><strong>Conclusions: </strong>FIN technique can be a dosimetrically preferable alternative to the commonly used SCVC for HDR VBT boost in patients with gynecological malignancies. It provides adequate coverage of target volumes, with minimal radiation dose to surrounding organs at risk.</p>\",\"PeriodicalId\":51305,\"journal\":{\"name\":\"Journal of Contemporary Brachytherapy\",\"volume\":\"16 3\",\"pages\":\"219-224\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11609860/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Contemporary Brachytherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5114/jcb.2024.141169\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/6/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Contemporary Brachytherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5114/jcb.2024.141169","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/28 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:比较单通道阴道圆筒(SCVC)和徒手间质针(FIN)阴道近距离放射治疗(VBT)的剂量学差异。材料与方法:对22例妇科恶性肿瘤患者术后行图像引导高剂量率(HDR)近距离放射治疗和外束放射治疗(EBRT)进行前瞻性治疗。所有HDR治疗均采用FIN植入技术。仅出于剂量学比较的目的,所有患者均放置直径为2.5 cm的scvc。在临床治疗过程中,未发现有传染源存在于圆筒涂抹器内。根据GEC-ESTRO指南进行ct引导下的近距离治疗计划,根据临床检查和MRI T2序列划定高危临床靶体积(HR-CTV)。比较了间质方案对HR-CTV和周围危险器官(OARs)的剂量-体积参数。结果:与SCVC组相比,FIN组HR-CTV覆盖率相同。FIN组V150%、V200%高于对照组(p < 0.05)。此外,它还具有较低的HI (p < 0.05)。FIN组直肠D0.1cc(538.5±119.8 cGy)、D1cc(415.4±73.3 cGy)、D2cc(355.7±66.6 cGy)、Dmean(162.8±43.7 cGy)及膀胱D0.1cc(516.1±85.2 cGy)、D1cc(392.9±59.8 cGy)剂量均低于SCVC组(p < 0.05)。结论:在妇科恶性肿瘤患者中,FIN技术可以作为一种剂量学上较好的替代常用的SCVC来提高HDR VBT。它提供了足够的靶体积覆盖,对周围有危险的器官的辐射剂量最小。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Dosimetric comparison between single-channel vaginal cylinder and free-hand interstitial needles in vaginal brachytherapy of gynecological cancers.

Purpose: To compare the dosimetric differences in vaginal brachytherapy (VBT) using single-channel vaginal cylinder (SCVC) and free-hand interstitial needles (FIN).

Material and methods: Twenty-two women with malignant gynecologic tumors were prospectively treated with image-guided high-dose-rate (HDR) brachytherapy after surgery and external beam radiation therapy (EBRT). All HDR treatments were delivered using FIN implant technique. For dosimetric comparison purposes only, SCVCs of 2.5 cm diameter were placed in all patients. No sources were dwelled in cylinder applicator during clinical treatment. CT-guided brachytherapy treatment planning was performed according to GEC-ESTRO guidelines, with high-risk clinical target volume (HR-CTV) delineated based on clinical exams and MRI T2 sequences. Dose-volume parameters to HR-CTV and surrounding organs at risk (OARs) from interstitial plans were compared with those achieved from cylinder plans.

Results: Compared with SCVC group, FIN group showed the same HR-CTV coverage. FIN group had higher V150% and V200% (p < 0.05). In addition, it had lower HI (p < 0.05). However, doses to the rectum D0.1cc (538.5 ±119.8 cGy), D1cc (415.4 ±73.3 cGy), D2cc (355.7 ±66.6 cGy), and Dmean (162.8 ±43.7 cGy) as well as the bladder D0.1cc (516.1 ±85.2 cGy) and D1cc (392.9 ±59.8 cGy) were lower in FIN group than in SCVC group (p < 0.05).

Conclusions: FIN technique can be a dosimetrically preferable alternative to the commonly used SCVC for HDR VBT boost in patients with gynecological malignancies. It provides adequate coverage of target volumes, with minimal radiation dose to surrounding organs at risk.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Contemporary Brachytherapy
Journal of Contemporary Brachytherapy ONCOLOGY-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
CiteScore
2.40
自引率
14.30%
发文量
54
审稿时长
16 weeks
期刊介绍: The “Journal of Contemporary Brachytherapy” is an international and multidisciplinary journal that will publish papers of original research as well as reviews of articles. Main subjects of the journal include: clinical brachytherapy, combined modality treatment, advances in radiobiology, hyperthermia and tumour biology, as well as physical aspects relevant to brachytherapy, particularly in the field of imaging, dosimetry and radiation therapy planning. Original contributions will include experimental studies of combined modality treatment, tumor sensitization and normal tissue protection, molecular radiation biology, and clinical investigations of cancer treatment in brachytherapy. Another field of interest will be the educational part of the journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信